Improved pharmacotherapy after revised dosing regimens of two slow-release formulations of benzylpenicillin in an Actinobacillus pleuropneumoniae infection model in pigs
Abstract Background Actinobacillus pleuropneumoniae (APP) is a Gram-negative bacterium that causes respiratory disease in pigs, resulting in significant economic losses and reduced animal welfare. In Sweden, the drug of choice for treatment of APP infections is benzylpenicillin. However, limited pha...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-04-01
|
| Schriftenreihe: | Acta Veterinaria Scandinavica |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s13028-025-00806-9 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
